blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2195035

EP2195035 - HIGH CONCENTRATION CHITOSAN-NUCLEIC ACID POLYPLEX COMPOSITIONS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  12.10.2018
Database last updated on 09.04.2026
FormerThe patent has been granted
Status updated on  03.11.2017
FormerGrant of patent is intended
Status updated on  25.07.2017
Most recent event   Tooltip03.07.2020Lapse of the patent in a contracting state
New state(s): CY		published on 05.08.2020  [2020/32]
Applicant(s)For all designated states
enGene, Inc.
7171 Frederick-Banting
Montreal, QC H4S 1Z9 / CA
[2018/15]
Former [2017/34]For all designated states
enGene, Inc.
100-2386 East Mall
Vancouver, BC V6T 1Z3 / CA
Former [2010/24]For all designated states
Engene, Inc.
100-2386 East Mall
Vancouver, BC V6T 1Z3 / CA
Inventor(s)01 / HSU, Eric, C.
5870 Fremlin Street
Vancouver, British Columbia V5Z 3W7 / CA
02 / FLEET, Carlos
1114 Wellington Drive
North Vancouver, British Columbia V7K 1L2 / CA
03 / CHEUNG, Anthony
688 Citadel Parade
Vancouver, British columbia V6B 1W8 / CA
04 / GAO, Jun
607 Langside Avenue
Coquitlam, British Columbia V3J 2Y7 / CA
 [2010/24]
Representative(s)Secerna LLP
The Old Fire Station
18 Clifford Street
York YO1 9RD / GB
[N/P]
Former [2014/08]Secerna LLP
The Catalyst
Baird Lane, Heslington East
York YO10 5GA / GB
Former [2010/24]Vossius & Partner
Siebertstrasse 4
81675 München / DE
Former [2010/24]Vossius & Partner
Siebertstraße 4
81675 München / DE
Application number, filing date08833604.526.09.2008
[2010/24]
WO2008CA01714
Priority number, dateUS20070976316P28.09.2007         Original published format: US 976316 P
[2010/24]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009039657
Date:02.04.2009
Language:EN
[2009/14]
Type: A1 Application with search report 
No.:EP2195035
Date:16.06.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 02.04.2009 takes the place of the publication of the European patent application.
[2010/24]
Type: B1 Patent specification 
No.:EP2195035
Date:06.12.2017
Language:EN
[2017/49]
Search report(s)International search report - published on:CA02.04.2009
(Supplementary) European search report - dispatched on:EP24.01.2012
ClassificationIPC:A61K48/00, A61K31/7088, C07H21/00, C12N15/10, C12N15/87
[2010/24]
CPC:
A61K31/7088 (EP,US); C08B37/0063 (US); C07H17/02 (EP,US);
C12N15/87 (EP,US); Y10T428/2982 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2017/49]
Former [2010/24]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:HOCHKONZENTRIERTE CHITOSAN-NUKLEINSÄURE-POLYPLEXZUSAMMENSETZUNGEN[2010/24]
English:HIGH CONCENTRATION CHITOSAN-NUCLEIC ACID POLYPLEX COMPOSITIONS[2010/24]
French:COMPOSITIONS DE POLYPLEXES CHITOSANE-ACIDE NUCLÉIQUE À CONCENTRATION ÉLEVÉE[2010/24]
Entry into regional phase30.03.2010National basic fee paid 
30.03.2010Search fee paid 
30.03.2010Designation fee(s) paid 
30.03.2010Examination fee paid 
Examination procedure30.03.2010Amendment by applicant (claims and/or description)
30.03.2010Examination requested  [2010/24]
06.06.2014Despatch of a communication from the examining division (Time limit: M06)
11.12.2014Reply to a communication from the examining division
25.02.2016Despatch of a communication from the examining division (Time limit: M04)
05.07.2016Reply to a communication from the examining division
26.07.2017Communication of intention to grant the patent
27.10.2017Fee for grant paid
27.10.2017Fee for publishing/printing paid
27.10.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  06.06.2014
Opposition(s)07.09.2018No opposition filed within time limit [2018/46]
Fees paidRenewal fee
14.09.2010Renewal fee patent year 03
26.09.2011Renewal fee patent year 04
26.10.2012Renewal fee patent year 05
18.11.2013Renewal fee patent year 06
12.09.2014Renewal fee patent year 07
11.09.2015Renewal fee patent year 08
13.09.2016Renewal fee patent year 09
12.09.2017Renewal fee patent year 10
Penalty fee
Additional fee for renewal fee
30.09.201205   M06   Fee paid on   26.10.2012
30.09.201306   M06   Fee paid on   18.11.2013
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU26.09.2008
CY06.12.2017
CZ06.12.2017
EE06.12.2017
HR06.12.2017
LT06.12.2017
LV06.12.2017
MC06.12.2017
RO06.12.2017
SK06.12.2017
TR06.12.2017
BG06.03.2018
GR07.03.2018
[2020/32]
Former [2020/28]HU26.09.2008
CZ06.12.2017
EE06.12.2017
HR06.12.2017
LT06.12.2017
LV06.12.2017
MC06.12.2017
RO06.12.2017
SK06.12.2017
TR06.12.2017
BG06.03.2018
GR07.03.2018
Former [2020/16]CZ06.12.2017
EE06.12.2017
HR06.12.2017
LT06.12.2017
LV06.12.2017
MC06.12.2017
RO06.12.2017
SK06.12.2017
TR06.12.2017
BG06.03.2018
GR07.03.2018
Former [2019/24]CZ06.12.2017
EE06.12.2017
HR06.12.2017
LT06.12.2017
LV06.12.2017
MC06.12.2017
RO06.12.2017
SK06.12.2017
BG06.03.2018
GR07.03.2018
Former [2018/42]CZ06.12.2017
EE06.12.2017
HR06.12.2017
LT06.12.2017
LV06.12.2017
RO06.12.2017
SK06.12.2017
BG06.03.2018
GR07.03.2018
Former [2018/37]CZ06.12.2017
EE06.12.2017
HR06.12.2017
LT06.12.2017
LV06.12.2017
SK06.12.2017
BG06.03.2018
GR07.03.2018
Former [2018/25]HR06.12.2017
LT06.12.2017
LV06.12.2017
BG06.03.2018
GR07.03.2018
Former [2018/23]HR06.12.2017
LT06.12.2017
GR07.03.2018
Documents cited:Search[XY] WO03092740  (ARTURSSON PER et al.) [X] 1-4,8-10,13,14 * page 13, lines 26-28; claim 16 * * page 12, lines 29-30 *[Y] 5-7,11,12
 [XY] WO03092739  (ARTURSSON PER et al.) [X] 1,2,8-10,13,14 * page 12, lines 10-22; examples 3,5 *[Y] 5-7,11,12
 [X] WO2006028323  (GOODGENE INC et al.) [X] 1,2,6,13,14 * page 23 *
International search[X]   KPING-HGGARD, M. ET AL.: "Chitosan as a nonviral gene delivery system. Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo.", GENE THERAPY., vol. 8, no. 14, July 2001 (2001-07-01), pages 1108 - 21, XP002967348 [X]

DOI:   http://dx.doi.org/10.1038/sj.gt.3301492
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.